SLC5A2 and type 1 diabetes mellitus: Currently, the latest UK Kidney Association guidelines recommend the use of SGLT2 inhibitors in patients with T1DM if they have an eGFR ≥ 20 mL/min/1.73 m2 and a uACR ≥ 25 mg/mmol under the strict direction of a specialized diabetologist (37).